Literature DB >> 22716154

Neurological soft signs in patients with psychosis and cannabis abuse: a systematic review and meta-analysis of paradox.

Miguel Ruiz-Veguilla1, Luis F Callado, Maite Ferrin.   

Abstract

BACKGROUND: Although neurological soft signs (NSSs) have been consistently associated with schizophrenia and a variety of risk factors, few studies have focused on the association between NSSs and environmental factors such as cannabis use, particularly in patients with first episode psychosis (FEP). AIMS: To review studies that have specifically investigated the association between NSSs and cannabis use in subjects who suffer from psychosis, and more specifically in FEP.
METHODS: A review of studies investigating the associations between neurological function in psychotic patients and cannabis use.
RESULTS: A total of 5 studies met our inclusion criteria. Two of these included data only from patients with FEP. Four studies concluded that patients with psychosis and particularly FEP who consumed cannabis showed fewer NSSs.
CONCLUSIONS: Four possible explanations are suggested for the paradoxical relationship between cannabis use and NSSs in FEP. First, heavy cannabis users present with different acute responses to cannabis use than do occasional cannabis users. Second, the psychoses developed by patients who consume cannabis follow different physio-pathological pathways that include fewer neurodevelopmental abnormalities. Third, the direct effect of cannabis on the Central Nervous System (CNS) may be responsible for the paradox. Finally,severe NSSsare associated with other clinical characteristics that would limit a subject's personal access to cannabis.

Entities:  

Mesh:

Year:  2012        PMID: 22716154     DOI: 10.2174/138161212802884753

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  9 in total

Review 1.  Cannabinoids and Schizophrenia: Risks and Therapeutic Potential.

Authors:  Marc W Manseau; Donald C Goff
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

2.  The adverse health effects and harms related to marijuana use: an overview review.

Authors:  K Ally Memedovich; Laura E Dowsett; Eldon Spackman; Tom Noseworthy; Fiona Clement
Journal:  CMAJ Open       Date:  2018-08-16

3.  Adolescent cannabis use and adult psychoticism: A longitudinal co-twin control analysis using data from two cohorts.

Authors:  Jonathan D Schaefer; Seon-Kyeong Jang; Scott Vrieze; William G Iacono; Matt McGue; Sylia Wilson
Journal:  J Abnorm Psychol       Date:  2021-09-23

4.  Altered Signaling in CB1R-5-HT2AR Heteromers in Olfactory Neuroepithelium Cells of Schizophrenia Patients is Modulated by Cannabis Use.

Authors:  Daniel Guinart; Estefanía Moreno; Liliana Galindo; Aida Cuenca-Royo; Marta Barrera-Conde; Ezequiel J Pérez; Cristina Fernández-Avilés; Christoph U Correll; Enric I Canela; Vicent Casadó; Arnau Cordomi; Leonardo Pardo; Rafael de la Torre; Víctor Pérez; Patricia Robledo
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

5.  Cannabis use and cognitive functions in at-risk mental state and first episode psychosis.

Authors:  H Bugra; E Studerus; C Rapp; C Tamagni; J Aston; S Borgwardt; A Riecher-Rössler
Journal:  Psychopharmacology (Berl)       Date:  2013-06-12       Impact factor: 4.530

6.  Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis.

Authors:  Robin M Murray; Harriet Quigley; Diego Quattrone; Amir Englund; Marta Di Forti
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

7.  Neurological soft signs in Tunisian patients with first-episode psychosis and relation with cannabis use.

Authors:  Ahmed Mhalla; Bochra Ben Mohamed; Christoph U Correll; Badii Amamou; Anouar Mechri; Lotfi Gaha
Journal:  Ann Gen Psychiatry       Date:  2017-07-12       Impact factor: 3.455

8.  Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.

Authors:  Diego Quattrone; Laura Ferraro; Giada Tripoli; Caterina La Cascia; Harriet Quigley; Andrea Quattrone; Hannah E Jongsma; Simona Del Peschio; Giusy Gatto; Charlotte Gayer-Anderson; Peter B Jones; James B Kirkbride; Daniele La Barbera; Ilaria Tarricone; Domenico Berardi; Sarah Tosato; Antonio Lasalvia; Andrei Szöke; Celso Arango; Miquel Bernardo; Julio Bobes; Cristina Marta Del Ben; Paulo Rossi Menezes; Pierre-Michel Llorca; Jose Luis Santos; Julio Sanjuán; Andrea Tortelli; Eva Velthorst; Lieuwe de Haan; Bart P F Rutten; Michael T Lynskey; Tom P Freeman; Pak C Sham; Alastair G Cardno; Evangelos Vassos; Jim van Os; Craig Morgan; Ulrich Reininghaus; Cathryn M Lewis; Robin M Murray; Marta Di Forti
Journal:  Psychol Med       Date:  2020-03-18       Impact factor: 7.723

9.  Marijuana Use and Perceptions of Risk and Harm: A Survey among Canadians in 2016.

Authors:  Eldon Spackman; Rebecca Haines-Saah; Vishva M Danthurebandara; Laura E Dowsett; Tom Noseworthy; Fiona M Clement
Journal:  Healthc Policy       Date:  2017-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.